Bioretina Inc Ankara University Technopolis
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 18
- 试验地点
- 4
- 主要终点
- ETDRS visual acuity:
研究概览
简要总结
The axons of the retinal ganglion cells combine to form the optic nerve. The optic nerve transmits electrical signals to the visual cortex by various synapses. Optic nerve axons are more sensitive to toxins than retina because they are outside the blood retinal barrier. Methanol, various solvents and heavy metals, carbon dioxide, antiarrhythmic, antiepileptic, antibiotics and some vasoactive drugs can cause toxic optic neuropathy. There is a different pathophysiology for each toxin. Methanol is easily accessible alcohol in all types of disinfectants. Methanol is converted into formaldehyde and formic acid while metabolized in the liver. Formaldehyde disrupts ATP synthesis by blocking mitochondrial function and oxidative phosphorylation. Formic acid causes demyelination as a result of metabolic acidosis. Neuroinflammation occurs when denatured proteins block axoplasmic flow. All these processes can lead to apoptosis and permanent vision loss. Sildenafil is a vasoactive drug used in erectile dysfunction. Sildenafil decreases optic nerve head blood flow. Neuroinflammation develops secondary to the cessation of axoplasmic flow after hypoxia. If hypoxia and neuroinflammatiom persists, apoptosis and permanent vision loss develop. Amiodarone is an ion channel blocker used in the treatment of cardiac arrhythmias. Long-term use may cause disruption of ion channel balance in the optic nerve. This condition leads to asymmetric neuroinflammation and apoptosis.
Wharton's jelly derived mesenchymal stem cells (WJ-MSC) can increase mitochondrial ATP synthesis with paracrine effects and suppress neuroinflammation with immunomodulatory effects. Repetitive electromagnetic stimulation (rEMS) can rearrange ion channel balances and axoplasmic flow. The aim of this prospective phase-3 clinical study is to investigate the effect of WJ-MSC and rEMS combination in the therapy of toxic optic neuropathies. This combination is the first study in the literature for the therapy of toxic optic neuropathies.
详细描述
This prospective, open-label clinical phase-3 study was conducted at Ankara University Faculty of Medicine, Department of Ophthalmology between April 2019 and April 2021. Thirty-six eyes of 18 patients with toxic optic neuropathy were included in the study. The primary toxic optic neuropathy (TON) diagnosis was made in emergency or intensive care clinics. Patients who admitted within 3 months after the first intervention were included in the study. All patients enrolled underwent a complete routine ophthalmic examination, including the best-corrected visual acuity (BCVA) measurement with the early treatment of diabetic retinopathy study (ETDRS) chart (Topcon CC 100 XP, Japan). The patients were further evaluated with optical coherence tomography angiography (OCTA) from RTVue XR (Avanti, Optovue, Fremont, CA, USA) to analyse and measure the changes in the ganglion cell complex (GCC) layer that provided a typical co-registered en-face and cross-sectional multimodal imaging platform. Functional evaluation of optic nerve was followed by Compass 24/2 visual field (VF) test (Compass, CenterVue, Padova, Italy) and 120' pattern visual evoked potential (pVEP) test (Mon 2018F, Metrovision, Perenchies, France).
Subjects Thirty-six eyes of 18 TON patients were included in the study.
Inclusion criteria consisted of several parameters:
- Cases poisoned with a toxic agent within 3 months
- Patients with BCVA better than 35 letters
- Any degree of visual field loss
- Patients over 18 years old
Exclusion criteria consisted of several parameters:
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Cases poisoned with a toxic agent within 3 months
- •Patients with BCVA better than 35 letters
- •Any degree of visual field loss
- •Patients over 18 years old
排除标准
- •Cases poisoned with a toxic agent more than 3 months
- •Patients with BCVA less than 35 letters: to perform the visual field test correctly
- •Neurological sequelae that cannot be cooperated
结局指标
主要结局
ETDRS visual acuity:
时间窗: Change from baseline BCVA at 3 months
The visual acuity scores obtained from the T0 and T2 examinations were analyzed and compared using statistical tests to determine effectiveness.
次要结局
- Visual field sensitivity: Fundus perimetry deviation index (FPDI, %)(Change from baseline FPDI at 3 months)
- Ganglion cell complex thickness (GCC thickness, µm):(Change from baseline GCC thickness at 3 months)
- Pattern visual evoked potential (pVEP)(Change from baseline p100 latency and amolitude at 3 months)
研究者
Umut Arslan
Principal Investigator
Ankara Universitesi Teknokent
